Literature DB >> 20110522

Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients.

Jérôme Avouac1, Paolo Airò, Philippe Dieude, Paola Caramaschi, Kiet Tiev, Elisabeth Diot, Jean Sibilia, Susanna Cappelli, Brigitte Granel, Alessandra Vacca, Julien Wipff, Olivier Meyer, André Kahan, Marco Matucci-Cerinic, Yannick Allanore.   

Abstract

OBJECTIVE: To assess the prevalence and potential associations with the systemic sclerosis (SSc) phenotype of additional autoimmune diseases (AID).
METHODS: A multicenter study was performed in France and Italy to recruit consecutive European Caucasian patients with SSc systematically assessed for the coexistence of predefined AID known to occur with connective tissue diseases.
RESULTS: We recruited 585 French and 547 Italian patients with SSc. Specific AID were found in 114/585 (19%) French and 179/547 (33%) Italians with SSc (p < 0.0001). Sjögren's syndrome and thyroiditis were the predominant AID in both cohorts (12% for Sjögren's syndrome and 6% for thyroiditis in the combined populations). The frequency of myositis, primary biliary cirrhosis, rheumatoid arthritis, and systemic lupus erythematosus was low (< 4%) and similar in both cohorts. The coexistence of at least 1 of the AID in the whole cohort was associated in multivariate analysis with the limited cutaneous subtype, the presence of antinuclear antibodies, and a lower prevalence of digital ulcers.
CONCLUSION: Our study shows that 21% of this large series of European Caucasian patients with SSc have developed at least 1 AID. This latter condition identified a subset of patients with milder disease. Thus, associations of AID and autoimmune background in SSc have to be considered for further therapeutic and biological investigations in SSc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110522     DOI: 10.3899/jrheum.090815

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  Unraveling the genetic component of systemic sclerosis.

Authors:  José Ezequiel Martín; Lara Bossini-Castillo; Javier Martín
Journal:  Hum Genet       Date:  2012-01-05       Impact factor: 4.132

2.  Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis.

Authors:  Baptiste Coustet; Matthieu Bouaziz; Philippe Dieudé; Mickael Guedj; Lara Bossini-Castillo; Sandeep Agarwal; Timothy Radstake; Javier Martin; Pravitt Gourh; Muriel Elhai; Eugénie Koumakis; Jérôme Avouac; Barbara Ruiz; Maureen Mayes; Frank Arnett; Eric Hachulla; Elisabeth Diot; Jean-Luc Cracowski; Kiet Tiev; Jean Sibilia; Luc Mouthon; Camille Frances; Zahir Amoura; Patrick Carpentier; Anne Cosnes; Olivier Meyer; André Kahan; Catherine Boileau; Gilles Chiocchia; Yannick Allanore
Journal:  J Rheumatol       Date:  2012-03-15       Impact factor: 4.666

3.  The co-occurrence of Hashimoto thyroiditis in primary Sjogren's syndrome defines a subset of patients with milder clinical phenotype.

Authors:  Paola Caramaschi; Domenico Biasi; Cristian Caimmi; Cinzia Scambi; Sara Pieropan; Giovanni Barausse; Silvano Adami
Journal:  Rheumatol Int       Date:  2012-11-05       Impact factor: 2.631

Review 4.  Systemic sclerosis and primary biliary cholangitis: An overlapping entity?

Authors:  Gemma Lepri; Silvia Bellando Randone; Marco Matucci Cerinic; Yannick Allanore
Journal:  J Scleroderma Relat Disord       Date:  2018-10-25

5.  New insight on the Xq28 association with systemic sclerosis.

Authors:  F David Carmona; M Carmen Cénit; Lina-Marcela Diaz-Gallo; Jasper C A Broen; Carmen P Simeón; Patricia E Carreira; José-Luis Callejas-Rubio; Vicente Fonollosa; Francisco J López-Longo; Miguel A González-Gay; Nicolas Hunzelmann; Gabriela Riemekasten; Torsten Witte; Alexander Kreuter; Jörg H W Distler; Rajan Madhok; Paul Shiels; Jacob M van Laar; Annemie J Schuerwegh; Madelon C Vonk; Alexandre E Voskuyl; Carmen Fonseca; Christopher P Denton; Ariane Herrick; Jane Worthington; Frank C Arnett; Filemon K Tan; Shervin Assassi; Timothy R D J Radstake; Maureen D Mayes; Javier Martín
Journal:  Ann Rheum Dis       Date:  2013-02-26       Impact factor: 19.103

6.  Raynaud's phenomenon, inflammatory arthritis, and weight loss: pay attention to the man behind the curtain.

Authors:  George Stojan; Peter B Illei; Rex C Yung; Allan C Gelber
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-08       Impact factor: 4.794

7.  Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis.

Authors:  L M Diaz-Gallo; P Gourh; J Broen; C Simeon; V Fonollosa; N Ortego-Centeno; S Agarwal; M C Vonk; M Coenen; G Riemekasten; N Hunzelmann; R Hesselstrand; F K Tan; J D Reveille; S Assassi; F J García-Hernandez; P Carreira; M T Camps; A Fernandez-Nebro; P Garcia de la Peña; T Nearney; D Hilda; M A González-Gay; P Airo; L Beretta; R Scorza; A Herrick; J Worthington; A Pros; I Gómez-Gracia; L Trapiella; G Espinosa; I Castellvi; T Witte; F de Keyser; M Vanthuyne; M D Mayes; T R D J Radstake; F C Arnett; J Martin; B Rueda
Journal:  Ann Rheum Dis       Date:  2010-12-03       Impact factor: 19.103

8.  Aldolase predicts subsequent myopathy occurrence in systemic sclerosis.

Authors:  Cécile Tolédano; Murielle Gain; Adrien Kettaneh; Bruno Baudin; Catherine Johanet; Patrick Chérin; Sébastien Rivière; Jean Cabane; Kiet Phong Tiev
Journal:  Arthritis Res Ther       Date:  2012-06-22       Impact factor: 5.156

9.  Introducing polyautoimmunity: secondary autoimmune diseases no longer exist.

Authors:  Adriana Rojas-Villarraga; Jenny Amaya-Amaya; Alberto Rodriguez-Rodriguez; Rubén D Mantilla; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2012-02-20

Review 10.  Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review.

Authors:  Korbinian Benz; Christine Baulig; Stephanie Knippschild; Frank Peter Strietzel; Nicolas Hunzelmann; Jochen Jackowski
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.